SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-190915
Filing Date
2022-07-11
Accepted
2022-07-11 07:38:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d378167d425.htm 425 562590
2 GRAPHIC g378167g0711100751259.jpg GRAPHIC 4229
3 GRAPHIC g378167g0711100751634.jpg GRAPHIC 2963
  Complete submission text file 0001193125-22-190915.txt   574577
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Subject) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-30319 | Film No.: 221075891
SIC: 2834 Pharmaceutical Preparations